These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6492826)

  • 21. Molecular orbital studies of epoxide stability of carcinogenic polycyclic aromatic hydrocarbon diol epoxides.
    Adams SM; Kaminsky LS
    Mol Pharmacol; 1982 Sep; 22(2):459-64. PubMed ID: 7144738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between biomarkers of polycyclic aromatic hydrocarbon exposure and electrophilic tissue burden in a rat model.
    Tzekova A; Thuot R; Viau C
    Arch Toxicol; 2004 Jun; 78(6):351-61. PubMed ID: 14749914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantum chemical and other theoretical studies of carcinogens, their metabolic activation and attack on DNA constituents.
    Kaufman JJ; Hariharan PC; Koski WS; Balasubramanian K
    Prog Clin Biol Res; 1985; 172A():263-75. PubMed ID: 3991675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of transplacental carcinogens.
    Anderson LM; Jones AB; Miller MS; Chauhan DP
    IARC Sci Publ; 1989; (96):155-88. PubMed ID: 2680945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability and potential carcinogenicity of polycyclic aromatic hydrocarbons from wood combustion particulate matter in vitro.
    Gauggel-Lewandowski S; Heussner AH; Steinberg P; Pieterse B; van der Burg B; Dietrich DR
    Chem Biol Interact; 2013 Nov; 206(2):411-22. PubMed ID: 23796820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The initiator tRNA acceptance assay as a short-term test for carcinogens. 6. Results with 78 polycyclic aromatic compounds.
    Hradec J; Seidel A; Platt KL; Glatt HR; Oesch F; Koblyakov V
    Carcinogenesis; 1990 Nov; 11(11):1921-6. PubMed ID: 2225323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of polycyclic aromatic hydrocarbon derivatives to ultimate carcinogens during lipid peroxidation.
    Dix TA; Marnett LJ
    Science; 1983 Jul; 221(4605):77-9. PubMed ID: 6304879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of some carcinogenic and non-carcinogenic polycyclic aromatic hydrocarbons on gap junction intercellular communication in hepatoma cell cultures.
    Sharovskaya J; Kobliakova I; Solomatina N; Kobliakov V
    Eur J Cell Biol; 2006 May; 85(5):387-97. PubMed ID: 16412531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of a bond reactivity index with carcinogenicity and metabolic activation of polycyclic aromatic hydrocarbons.
    Mohammad SN
    Indian J Biochem Biophys; 1984 Aug; 21(4):260-2. PubMed ID: 6526413
    [No Abstract]   [Full Text] [Related]  

  • 30. Structure, function and carcinogenicity of metabolites of methylated and non-methylated polycyclic aromatic hydrocarbons: a comprehensive review.
    Flesher JW; Lehner AF
    Toxicol Mech Methods; 2016; 26(3):151-79. PubMed ID: 26894797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect to carcinogenic potency.
    Sjögren M; Ehrenberg L; Rannug U
    Mutat Res; 1996 Oct; 358(1):97-112. PubMed ID: 8921980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical carcinogenesis and experimental models using human tissues.
    Harris C
    Beitr Pathol; 1976 Sep; 158(4):389-404. PubMed ID: 791246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites.
    Van de Wiele T; Vanhaecke L; Boeckaert C; Peru K; Headley J; Verstraete W; Siciliano S
    Environ Health Perspect; 2005 Jan; 113(1):6-10. PubMed ID: 15626640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatic metabolism of two carcinogenic dimethylbenz[c]acridines in control and induced rats: the distribution and the mutagenicity of metabolites.
    Ye Y; Scharping CE; Holder GM
    Carcinogenesis; 1995 Apr; 16(4):787-93. PubMed ID: 7728956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical aspects of chemical carcinogenesis.
    Gielen JE
    Bull Cancer; 1978; 65(3):249-54. PubMed ID: 719180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in mediated mutagenesis and polycyclic aromatic hydrocarbon metabolism in mammary cells from pregnant and virgin rats.
    Moore CJ; Gould MN
    Carcinogenesis; 1984 Jan; 5(1):103-8. PubMed ID: 6690080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of polycyclic aromatic hydrocarbons between model membranes: relation to carcinogenicity.
    Plant AL; Pownall HJ; Smith LC
    Chem Biol Interact; 1983 Jun; 44(3):237-46. PubMed ID: 6872092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.
    Rybicki BA; Nock NL; Savera AT; Tang D; Rundle A
    Cancer Lett; 2006 Aug; 239(2):157-67. PubMed ID: 16154258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.
    Conney AH
    Cancer Res; 1982 Dec; 42(12):4875-917. PubMed ID: 6814745
    [No Abstract]   [Full Text] [Related]  

  • 40. Researches on chemical carcinogens and mechanism of chemical carcinogenesis. Di-region theory--a quantitative molecular orbital model of carcinogenic activity for polycyclic aromatic hydrocarbons.
    Qianhuan D
    Sci Sin; 1980 Apr; 23(4):453-70. PubMed ID: 7403839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.